戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nophosphate (cGMP)-dependent protein kinase (G-kinase).
2 arget gene vinculin was also blocked by cGMP/G-kinase.
3 pha(13)-induced Rho.GTP loading inhibited by G-kinase.
4 ntin filament organization via activation of G-kinase.
5 ls transfected with a catalytically inactive G-kinase.
6  c-Raf is the major target for regulation by G-kinase.
7 reover, the ability of insulin to inactivate GS kinase-3beta (GSK-3beta), the regulatory enzyme immed
8  cyclic GMP (cGMP)-dependent protein kinase (G-kinase) activates the human fos promoter in a strictly
9                                              G-kinase activation inhibited SRF-dependent transcriptio
10 nalogs is strictly dependent on G-kinase and G-kinase activation inhibits the Ras/MAP kinase pathway
11  was mediated by the CRE and proportional to G-kinase activity.
12 lation with phosphorylation-related terms (e.g., kinase activity or protein phosphorylation), which w
13 e cyclase and cGMP-dependent protein kinase (G-kinase) activity, and CS-54 arterial smooth muscle cel
14 e cyclase and cGMP-dependent protein kinase (G-kinase) activity.
15 cription by interfering with RhoA signaling; G-kinase acts both upstream of RhoA, inhibiting serum- o
16                                              G kinase also catalyzed the phosphorylation of peptides
17 t there were significant differences between G-kinase and A-kinase activation of single enhancer elem
18 wth by cGMP analogs is strictly dependent on G-kinase and G-kinase activation inhibits the Ras/MAP ki
19 functions in cancer-associated phenotypes (e.g., kinase and cell cycle).
20 43 was insensitive to inhibition by cGMP and G-kinase, and expression of this mutant kinase protected
21                                The effect of G-kinase appeared to be mediated by several sequence ele
22          We identified a putative NLS in the G-kinase ATP binding domain which resembles the NLS of t
23 r elements requires nuclear translocation of G-kinase but not activation of mitogen-activated protein
24 xpression via cGMP-dependent protein kinase (G-kinase), but NO's precise mechanism of action is uncle
25 entration-dependent fashion, suggesting that G kinase catalyzes the phosphorylation of some proximal
26 ating our current findings with NOS, GC, and G kinase cycles is presented.
27 we report that transfection of G-kinase into G-kinase-deficient cells causes activation of the human
28 nase in G-kinase-expressing cells but not in G-kinase-deficient cells.
29 lular Ca(2+) waves, which were NO, cGMP, and G-kinase dependent, because incubating cells with nitric
30 al cells in a cGMP-dependent protein kinase (G-kinase)-dependent fashion.
31 esting regulation of C/EBP-beta functions by G-kinase-dependent dephosphorylation.
32 the fos promoter by a guanylate cyclase- and G-kinase-dependent mechanism.
33                                              G-kinase directly induced intermediate filament assembly
34 e and nuclear translocation of MAP kinase in G-kinase-expressing cells but not in G-kinase-deficient
35    Ras activation by EGF was not impaired in G-kinase-expressing cells treated with cGMP analogs.
36 ls co-transfected with guanylate cyclase and G-kinase expression vectors, CAT activity was increased
37 r analysis), or as functionally important (e.g., kinase fusions).
38                                              G-kinase had no effect on RhoA(63L)-induced morphologica
39                                              G-kinase had no effect on the high activation levels of
40                                      Soluble G-kinase I also regulates fos promoter activity, but mem
41                     Our results suggest that G-kinase I and II control gene expression by different m
42 s mapped to the N-terminal 93 amino acids of G-kinase I beta and one of six 95-amino acid repeats fou
43 P analogs enhanced co-immunoprecipitation of G-kinase I beta and TFII-I by inducing co-localization o
44  we performed a yeast two-hybrid screen with G-kinase I beta as bait.
45                                We found that G-kinase I beta interacted specifically with TFII-I, an
46 cally enhanced transcriptional activation by G-kinase I beta.
47 promoter activity, but membrane targeting of G-kinase I prevented the enzyme from translocating to th
48 location of cGMP-dependent protein kinase I (G-kinase I).
49               To identify nuclear targets of G-kinase I, we performed a yeast two-hybrid screen with
50 xtranuclear G-kinase II are not regulated by G-kinase I.
51 ll growth in cells stably transfected with a G-kinase Ibeta expression vector but not in untransfecte
52  empty vector or in cells transfected with a G-kinase Ibeta expression vector.
53  the transcriptional effects of extranuclear G-kinase II are not regulated by G-kinase I.
54 anslocate to the nucleus; however, a soluble G-kinase II mutant translocated to the nucleus and regul
55                                The effect of G-kinase II on gene expression did not require calcium u
56 O effects on neuronal plasticity may involve G-kinase II regulation of gene expression.
57                                              G-kinase II was membrane associated and did not transloc
58 ave no effect; (3) CREB is phosphorylated by G-kinase in vitro and its phosphorylation increases in v
59 ical structure, newer therapeutic targets (e.g., kinases), including a significant increase in the us
60 phorylation of the hepatic InsP3 receptor by G-kinase increases the sensitivity to InsP3 for [Ca2+]i
61                                Activation of G-kinase induced MAP kinase phosphatase 1 expression, bu
62                   We show that activation of G-kinase inhibited c-Raf kinase activation and that G-ki
63 c fashion with ROK being the most efficient; G-kinase inhibited transcription induced by all three ef
64 eficient VASP mutant can partly prevent cGMP/G-kinase inhibition of serum- and RhoA-induced SRE-depen
65                         We now show that the G-kinase inhibition that occurs downstream of RhoA can b
66 nses to cGMP analogues were inhibited by the G-kinase inhibitor 8-bromoguanosine-3',5'-cyclic monopho
67 itric oxide synthase, guanylate cyclase, and G-kinase inhibitors, or NO scavengers, reduced Delta[Ca(
68 f cell function by NO in which activation of G kinase inhibits signaling by G protein-coupled recepto
69                             We conclude that G-kinase inhibits SRF-dependent transcription by interfe
70         Cyclic GMP-dependent protein kinase (G-kinase) inhibits RhoA activation of SRE-dependent tran
71          Here we report that transfection of G-kinase into G-kinase-deficient cells causes activation
72 d its phosphorylation increases in vivo when G-kinase is activated either directly by cGMP or indirec
73 esults indicate that nuclear localization of G-kinase is required for transcriptional activation of t
74 gle amino acid residue (K407-->E) within the G-kinase NLS produced an enzyme with normal cGMP-depende
75                                Fusion of the G-kinase NLS to the N terminus of beta-galactosidase pro
76 e inhibited c-Raf kinase activation and that G-kinase phosphorylated c-Raf kinase on Ser43, both in v
77                                              G-kinase phosphorylated TFII-I in vitro and in vivo on S
78 patic type-1 InsP3 receptor, indicating that G-kinase phosphorylates the InsP3 receptor at sites targ
79  RhoA can be explained, at least in part, by G-kinase phosphorylation of VASP on Ser(239) at the carb
80 (ii) did not require cytosolic components, e.g., kinases, proteases, phosphatases, etc., because it o
81 lating SRE-dependent transcription, and that G-kinase regulates VASP activity.
82  for the cGMP/cGMP-dependent protein kinase (G-kinase) signal transduction pathway.
83      Results from this study suggest that NO-G-kinase signaling is coupled to Ca(2+) mobilization and
84 e (100-200 microM) and antagonists of the NO-G-kinase signaling pathway essentially abrogated the NO-
85  ryanodine receptor-linked store, via the NO-G-kinase signaling pathway.
86 tric oxide-cGMP-dependent protein kinase (NO-G-kinase) signaling pathway in glial intercellular Ca(2+
87                                              G-kinase strongly enhanced TFII-I transactivation of a s
88  EGF-induced MAP kinase activity by cGMP and G-kinase, suggesting that Ser43 in c-Raf is the major ta
89 cell types containing cytoplasmic TFII-I the G-kinase-TFII-I interaction was largely cGMP-independent
90 press type II cGMP-dependent protein kinase (G-kinase); the effect on the fos promoter was mediated b
91 Similarly, B-Raf kinase was not inhibited by G-kinase; the Ser43 phosphorylation site of c-Raf is not
92                                   Binding of G-kinase to TFII-I may position the kinase to phosphoryl
93                             The magnitude of G-kinase transactivation of the fos promoter was similar
94                    Our results indicate that G-kinase transduces signals to the nucleus independently
95                    Here, we demonstrate that G-kinase translocates to the nucleus by an active transp
96                Immunofluorescent staining of G-kinase was predominantly cytoplasmic in untreated cell
97  deficient in cGMP-dependent protein kinase (G-kinase), we show that 8-(4-chlorophenylthio)guanosine-
98                  Nanomolar concentrations of G kinase were found to catalyze the phosphorylation of p
99 and activates cGMP-dependent protein kinase (G kinase), which by an unknown mechanism leads to inhibi
100  that type II cGMP-dependent protein kinase (G-kinase), which is widely expressed in the brain, media
101 contrast, N-terminally truncated versions of G-kinase with constitutive, cGMP-independent activity in

 
Page Top